recent
outbreak
sar
influenza
underlin
threat
virus
anim
reservoir
pose
human
popul
fortun
neither
sar
influenza
becom
endem
human
nevertheless
event
stress
import
prepar
emerg
reemerg
infecti
diseas
infecti
diseas
vaccin
prefer
control
measur
inde
vaccin
gener
proven
highli
efficaci
provid
strong
longlast
immun
infect
diseas
transmiss
howev
case
previous
unknown
infecti
diseas
vaccin
may
readili
avail
emerg
infecti
diseas
control
option
limit
especi
viral
pathogen
treat
effect
antimicrobi
drug
pathogen
control
option
restrict
case
isol
contact
trace
promot
chang
behavior
vaccin
use
vaccin
poor
efficaci
antivir
drug
although
efficaci
current
avail
antivir
drug
also
far
perfect
although
antivir
drug
provid
protect
short
amount
time
advantag
antivir
drug
vaccin
broad
spectrum
action
newli
aris
viral
infecti
diseas
may
possibl
contain
outbreak
earli
stage
mean
largescal
antivir
control
program
control
program
start
earli
high
complianc
rate
efficaci
antivir
drug
suffici
high
transmiss
pathogen
suffici
low
henc
seem
logic
effort
gear
toward
earli
control
outbreak
howev
whether
peopl
cooper
contain
strategi
known
probabl
willing
particip
control
program
depend
perceiv
risk
infect
consequ
subsequ
diseas
compar
perceiv
risk
take
antivir
drug
advers
effect
take
antivir
drug
may
well
peopl
inclin
start
take
antivir
drug
risk
infect
becom
nonneglig
paper
employ
popul
dynam
game
theoret
analys
investig
condit
antivir
control
program
prevent
epidem
ii
peopl
consid
take
antivir
drug
regard
latter
question
take
two
perspect
first
focu
public
health
offic
whose
goal
minim
total
amount
damag
caus
infect
prophylact
antivir
treatment
second
step
compar
strategi
optim
point
view
popul
whole
strategi
would
evolv
individu
pursu
interest
dilemma
individu
face
follow
take
chanc
refus
antivir
prophylaxi
price
may
pay
upon
infect
may
high
death
extrem
consequ
potenti
reward
success
recov
infect
also
reap
benefit
longlast
immun
altern
take
antivir
drug
avoid
potenti
high
cost
infect
drawback
option
may
take
antivir
prolong
period
time
neg
sideeffect
short
term
may
long
run
also
harmless
situat
complic
fact
individu
risk
infect
depend
whether
individu
decid
take
antivir
drug
also
decis
other
context
vaccin
well
known
situat
trend
decreas
willing
particip
control
program
lead
strategi
optim
popul
perspect
ask
whether
similar
phenomena
occur
case
antivir
prophylaxi
vaccin
usual
provid
longlast
strong
immun
one
vaccin
bout
antivir
prophylact
therapi
reli
continu
administr
drug
impli
contrast
vaccin
individu
opportun
adjust
action
situat
face
earlier
studi
focu
rel
perceiv
risk
infect
compar
vaccin
consid
infect
antivir
drug
induc
real
albeit
possibl
small
risk
death
throughout
aim
deciph
optim
antivir
prophylact
control
strategi
mould
transmiss
pathogen
risk
associ
antivir
prophylaxi
efficaci
antivir
drug
reduc
suscept
infecti
mortal
would
like
stress
onset
strive
conceptu
clarif
precis
represent
specif
system
particular
analys
base
simplifi
assumpt
individu
act
ration
perfect
inform
foresight
engag
project
epidem
detail
popul
structur
play
minor
role
awar
simplifi
assumpt
neglect
real
world
therefor
believ
model
suit
make
quantit
predict
specif
emerg
infecti
diseas
rather
model
serv
purpos
lay
ideal
context
key
factor
shape
interest
individu
public
health
offic
case
influenza
vaccin
other
investig
model
ad
layer
complex
goal
make
quantit
predict
stochast
determinist
sirvtyp
epidem
model
individu
suscept
infect
infecti
recov
immun
r
partial
protect
infect
antivir
prophylact
treatment
v
form
basi
analys
figur
show
schemat
model
detail
given
text
throughout
suscept
individu
enter
popul
birth
natur
death
rate
suscept
recov
individu
denot
excess
mortal
antivir
treatment
given
henc
life
expect
absenc
infect
antivir
control
antivir
drug
infect
class
excess
death
rate
result
infect
given
avei
antivir
efficaci
infecti
virul
follow
refer
succinctli
cost
antivir
prophylaxi
infect
suscept
class
individu
move
protect
infect
class
rate
paramet
colloqui
call
forc
infect
depend
preval
infect
text
individu
class
v
infect
reduc
rate
ave
denot
antivir
efficaci
suscept
impli
individu
class
v
infect
ave
antivir
drug
provid
protect
infect
ave
final
rate
recoveri
noncompli
given
respect
overview
model
paramet
default
valu
given
tabl
detail
model
analys
provid
text
prophylact
antivir
control
program
abl
prevent
epidem
sever
studi
address
question
use
simul
metapopul
model
includ
household
structur
popul
pathogen
detail
focu
basic
model
larg
wellmix
popul
evalu
whether
success
invas
pathogen
possibl
calcul
basic
reproduct
number
denot
r
give
number
new
infect
caus
singl
infect
individu
popul
uninfect
individu
earli
stage
outbreak
r
pathogen
invad
popul
yet
present
r
case
pathogeninduc
mortal
hardli
affect
infecti
period
reproduct
number
given
see
text
deriv
first
factor
equat
give
reproduct
number
popul
consist
suscept
individu
second
factor
repres
sum
fraction
individu
suscept
protect
class
individu
protect
class
weigh
rel
suscept
rel
infecti
infect
notic
reproduct
number
increas
increas
pathogen
transmiss
length
infecti
period
increas
rate
individu
leav
protect
class
reproduct
number
decreas
increas
rate
antivir
prophylaxi
equat
show
pathogen
invad
popul
rate
antivir
prophylaxi
exce
certain
critic
rate
antivir
prophylact
therapi
given
solut
equat
r
default
paramet
valu
tabl
turn
critic
rate
antivir
prophylaxi
yr
antivir
drug
provid
complet
protect
infect
ave
impli
approxim
twothird
popul
need
protect
infect
antivir
prophylaxi
order
prevent
epidem
fraction
increas
antivir
drug
provid
partial
protect
infect
subsequ
transmiss
possibl
prevent
major
epidem
antivir
respons
start
quickli
introduct
pathogen
answer
question
perform
stochast
simul
antivir
respons
initi
certain
number
individu
infect
see
text
detail
figur
show
three
repres
simul
run
epidem
larg
finit
popul
individu
control
measur
put
place
top
panel
epidemiolog
theori
inform
larg
epidem
unfold
probabl
fraction
individu
infect
epidem
taken
roughli
given
solut
final
size
equat
log
x
default
paramet
valu
mean
popul
infect
die
sequela
infect
popul
one
million
individu
impli
individu
die
cours
epidem
situat
complet
differ
largescal
antivir
prophylact
control
program
initi
certain
number
individu
infect
middl
bottom
panel
figur
show
simul
case
perfect
imperfect
antivir
drug
respect
panel
assum
antivir
control
start
individu
infect
individu
exempt
antivir
drug
treatment
middl
panel
show
even
though
cost
antivir
prophylaxi
much
smaller
cost
infect
tabl
number
individu
die
antivir
treatment
end
epidem
equal
number
die
infect
individu
antivir
drug
imperfect
bottom
panel
durat
epidem
consider
longer
mani
individu
die
antivir
treatment
infect
versu
still
total
number
death
order
magnitud
smaller
case
antivir
control
program
effect
simul
figur
illustr
two
gener
phenomena
first
number
infect
death
reduc
dramat
antivir
control
program
abl
success
contain
epidem
second
number
death
caus
infect
proport
number
infect
individu
rel
small
earli
stage
epidem
number
death
relat
antivir
prophylaxi
proport
number
individu
taken
antivir
drug
latter
may
quit
larg
probabl
order
total
popul
size
henc
even
though
individu
risk
antivir
prophylaxi
small
largescal
antivir
prophylact
control
appear
ration
strategi
may
well
number
death
induc
antivir
treatment
exce
number
death
induc
infect
motiv
observ
investig
follow
condit
largescal
antivir
control
program
abl
halt
epidem
ii
condit
ration
individu
will
take
antivir
drug
point
unfold
epidem
risk
infect
exceed
risk
antivir
treatment
question
relev
determin
incent
individu
take
antivir
drug
focu
probabl
individu
aliv
certain
time
horizon
given
initi
suscept
partial
protect
infect
antivir
control
probabl
remain
aliv
larger
initi
suscept
antivir
treatment
best
option
take
antivir
drug
otherwis
revers
true
formal
analys
given
text
summar
main
find
figur
show
relat
horizon
critic
forc
infect
determin
whether
individu
take
antivir
drug
critic
forc
infect
strongli
depend
cost
antivir
treatment
fact
risk
antivir
treatment
low
yr
critic
forc
infect
rang
yr
yr
horizon
one
month
longer
assum
standard
relat
forc
infect
preval
infect
see
text
impli
individu
consid
take
antivir
drug
preval
infect
rang
henc
take
antivir
drug
ration
strategi
three
four
person
infect
popul
one
million
cost
antivir
treatment
increas
one
order
magnitud
critic
forc
infect
also
increas
approxim
one
order
magnitud
risk
infect
outweigh
risk
antivir
prophylaxi
approxim
individu
infect
cost
antivir
treatment
increas
anoth
order
magnitud
yr
critic
forc
infect
increas
order
magnitud
take
antivir
drug
ration
strategi
individu
infect
figur
show
two
repres
simul
run
pathogen
dynam
individu
base
decis
whether
take
antivir
drug
critic
forc
infect
forc
infect
remain
smaller
critic
forc
infect
ie
number
infect
individu
remain
certain
threshold
incent
take
antivir
drug
revers
true
forc
infect
exce
critic
forc
infect
default
paramet
valu
threshold
reach
individu
infect
popul
million
top
panel
show
unfold
epidem
principl
halt
littl
cost
human
live
bottom
panel
illustr
high
complianc
rate
essenti
success
earli
control
prevent
rapid
buildup
suscept
individu
number
infect
individu
drop
threshold
let
us
suppos
attempt
control
outbreak
earli
stage
unsuccess
case
still
interest
determin
whether
condit
antivir
prophylaxi
part
strategi
aim
pathogen
erad
contain
antivir
treatment
provid
complet
protect
infect
ave
equilibrium
preval
infect
decreas
monoton
increas
rate
antivir
control
point
pathogen
persist
text
furthermor
long
risk
antivir
prophylaxi
remain
small
precis
valu
hardli
affect
preval
infect
due
fact
mortal
relat
antivir
treatment
neglig
comparison
natur
mortal
although
risk
antivir
prophylaxi
may
neglig
effect
preval
infect
affect
excess
mortal
equilibrium
induc
infect
antivir
treatment
fact
case
perfect
antivir
drug
excess
mortal
decreas
increas
rate
antivir
prophylaxi
ie
cost
antivir
prophylaxi
small
compar
cost
infect
impli
equilibrium
excess
mortal
lowest
point
pathogen
driven
extinct
hand
inequ
revers
excess
mortal
increas
increas
rate
antivir
prophylaxi
excess
mortal
lowest
antivir
drug
taken
default
paramet
valu
righthand
side
inequ
equal
yr
cost
antivir
prophylaxi
yr
henc
default
scenario
excess
mortal
decreas
increas
rate
antivir
control
point
pathogen
unabl
persist
yr
next
turn
attent
differ
perspect
individu
versu
public
health
offic
focu
antivir
treatment
rate
minim
excess
mortal
minim
quantiti
respect
antivir
treatment
rate
yield
strategi
optim
popul
perspect
throughout
section
next
assum
pathogen
endem
present
popul
dynam
equilibrium
argu
optim
popul
strategi
pathogen
unabl
persist
risk
antivir
prophylaxi
small
ie
satisfi
otherwis
optim
popul
strategi
take
antivir
drug
text
text
also
show
excess
mortal
small
group
individu
antivir
treatment
rate
calcul
popul
major
individu
take
antivir
drug
rate
allow
one
determin
antivir
treatment
strategi
evolv
popul
level
process
individu
choic
optim
popul
individu
rate
antivir
treatment
popul
level
denot
respect
figur
show
result
systemat
investig
relat
model
paramet
fraction
individu
take
antivir
drug
determin
antivir
control
rate
top
panel
show
fraction
individu
take
antivir
drug
black
line
associ
excess
mortal
grey
line
function
pathogen
transmiss
transmiss
low
yr
pathogen
persist
need
take
antivir
drug
transmiss
intermedi
posit
popul
optimum
ensur
erad
pathogen
individu
optimum
still
zero
transmiss
high
popul
individu
control
rate
posit
although
erad
achiev
optim
popul
control
rate
bottom
panel
figur
illustr
fraction
individu
take
antivir
drug
depend
antivir
death
rate
surprisingli
antivir
drug
incur
cost
popul
individu
optim
control
rate
pathogen
driven
extinct
default
paramet
valu
achiev
least
twothird
popul
antivir
drug
treatment
cost
antivir
treatment
best
option
drive
pathogen
extinct
one
take
popul
perspect
risk
antivir
prophylaxi
exce
risk
infect
endem
equilibrium
antivir
control
yr
altern
individu
allow
flexibl
adjust
strategi
optim
rate
antivir
prophylaxi
decreas
gradual
increas
antivir
death
rate
case
optim
rate
antivir
prophylaxi
zero
yr
notic
intermedi
cost
antivir
treatment
public
health
offic
favour
strategi
aim
erad
diseas
process
individu
choic
lead
situat
nobodi
will
take
antivir
drug
unfortun
date
antivir
drug
provid
complet
protect
infect
diseas
instanc
analysi
two
recent
trial
antivir
drug
oseltamivir
show
provid
littl
protect
infect
influenza
moder
protect
subsequ
shed
diseas
therefor
section
studi
consequ
antivir
prophylact
treatment
imperfect
antivir
drug
analys
take
ave
avei
default
paramet
valu
relat
antivir
efficaci
suscept
infecti
optim
rate
antivir
control
investig
figur
top
panel
show
relat
antivir
efficaci
suscept
optim
fraction
individu
take
antivir
drug
assum
antivir
efficaci
infecti
virul
fix
avei
fact
optim
fraction
take
antivir
drug
decreas
increas
antivir
efficaci
suscept
understood
follow
decreas
antivir
efficaci
suscept
render
antivir
drug
less
effect
howev
sinc
cost
antivir
treatment
low
antivir
efficaci
infecti
rel
high
ration
strategi
erad
pathogen
one
take
popul
perspect
decreas
antivir
efficaci
suscept
achiev
increas
rate
antivir
control
interestingli
top
panel
indic
one
take
individu
perspect
excess
mortal
highest
antivir
drug
provid
complet
protect
infect
sinc
optim
control
rate
lowest
bottom
panel
figur
show
relat
optim
fraction
individu
take
antivir
drug
function
antivir
efficaci
infecti
antivir
efficaci
suscept
fix
ave
pictur
panel
complic
top
panel
particular
erad
pathogen
feasibl
antivir
efficaci
infecti
drop
critic
valu
avei
antivir
efficaci
infecti
critic
valu
still
best
strategi
drive
pathogen
extinct
one
take
popul
perspect
howev
achiev
almost
individu
protect
class
hand
antivir
efficaci
infecti
low
avei
better
take
antivir
drug
benefit
take
antivir
drug
outweigh
cost
region
paramet
space
optim
control
rate
zero
intermedi
paramet
regim
avei
possibl
achiev
erad
may
nevertheless
wise
take
antivir
drug
fact
take
popul
perspect
alway
better
partial
protect
antivir
drug
fulli
suscept
region
paramet
space
ie
even
though
erad
possibl
intuit
may
seem
one
consid
antivir
treatment
face
highli
transmiss
pathogen
kill
host
howev
line
reason
may
inaccur
particular
notion
antivir
treatment
attract
drug
rel
harmless
potenti
larg
number
infectioninduc
death
prevent
necessarili
true
analys
show
cours
epidem
death
toll
consider
antivir
drug
taken
number
death
order
magnitud
smaller
largescal
antivir
control
program
effect
figur
howev
analys
also
show
epidem
effect
control
largescal
antivir
treatment
program
major
death
result
use
antivir
drug
intuit
explan
although
hazard
mortal
antivir
prophylaxi
small
shortterm
individu
level
total
death
toll
may
quit
high
number
individu
must
receiv
antivir
drug
effect
control
effort
probabl
order
total
popul
size
moreov
ad
fact
face
immin
threat
may
prove
necessari
continu
take
antivir
drug
prolong
period
earli
stage
unfold
epidem
probabl
infect
still
small
consequ
individu
may
tempt
put
antivir
drug
treatment
preval
infect
henc
probabl
infect
becom
nonneglig
analys
shown
critic
forc
infect
determin
point
individu
start
take
antivir
drug
depend
strongli
advers
effect
antivir
drug
use
figur
henc
purpos
success
prevent
earli
contain
import
advers
effect
antivir
drug
remain
small
analys
reveal
take
popul
perspect
best
option
either
provid
antivir
drug
point
pathogen
unabl
invad
persist
provid
antivir
drug
figur
depend
cost
antivir
treatment
effect
antivir
treatment
hand
one
take
individu
perspect
incent
take
less
antivir
drug
optim
popul
perspect
complet
prevent
erad
diseas
rare
possibl
interestingli
conflict
individu
public
health
offic
appear
pronounc
cost
antivir
drug
treatment
effect
antivir
drug
reduc
advers
effect
infect
intermedi
figur
fact
cost
antivir
prophylaxi
intermedi
possibl
public
health
favour
aggress
contain
strategi
aim
pathogen
erad
process
individu
choic
lead
situat
nobodi
will
take
antivir
drug
hand
cost
antivir
treatment
high
effect
antivir
drug
prevent
advers
effect
infect
low
conflict
may
becom
small
disappear
figur
one
aspect
model
deserv
special
attent
throughout
assum
cost
infect
antivir
treatment
term
increas
risk
death
conveni
enabl
straightforward
comparison
posit
neg
consequ
infect
antivir
prophylaxi
howev
although
question
human
infect
sar
avian
influenza
bring
along
risk
death
yet
unclear
sever
advers
effect
antivir
drug
treatment
may
especi
rare
possibl
sever
advers
effect
instanc
welldocu
oseltamivir
neuraminidas
inhibitor
current
use
treat
prevent
influenza
infect
frequent
lead
nausea
number
less
frequent
advers
effect
hepat
skin
reaction
recent
suggest
seriou
advers
effect
includ
neuropsychiatr
syndrom
may
contribut
number
suicid
event
japan
use
mortal
currenc
compar
cost
benefit
antivir
drug
use
previou
game
theoret
studi
vaccin
focus
rel
perceiv
risk
vaccin
compar
infect
therebi
also
introduc
common
currenc
compar
cost
benefit
vaccin
use
rel
perceiv
risk
vaccin
basi
comparison
advantag
easili
model
howev
approach
also
disadvantag
assum
payoff
loss
individu
choos
vaccin
fix
quantiti
rel
perceiv
cost
vaccin
unrel
actual
number
advers
event
popul
payoff
loss
individu
choos
vaccin
proport
preval
infect
take
account
discount
differ
cost
benefit
eg
individu
success
recov
infect
reap
longterm
benefit
prolong
immun
ultim
believ
game
theoret
model
one
analyz
refin
includ
dynam
human
risk
percept
model
perceiv
risk
infect
antivir
treatment
static
dynam
adjust
function
differ
type
advers
event
differ
type
morbid
death
actual
occur
popul
cours
dynam
human
risk
percept
model
straightforward
would
necessit
ad
fair
bit
sociolog
epidemicgam
theoret
model
throughout
paper
made
simplifi
assumpt
individu
public
health
offic
act
ration
perfect
inform
foresight
detail
popul
structur
antivir
drug
action
play
minor
role
assumpt
made
order
abl
keep
analys
manag
abl
focu
detail
conflict
interest
cours
awar
real
world
varieti
complic
factor
play
role
therefor
studi
intend
suit
make
quantit
predict
serv
explor
public
individu
interest
shape
pathogen
transmiss
cost
antivir
treatment
antivir
efficaci
suscept
infecti
would
interest
extend
model
number
direct
order
abl
make
specif
predict
specif
viral
threat
purpos
sever
step
taken
first
depend
precis
research
question
form
popul
structur
would
probabl
need
taken
account
instanc
goal
decid
limit
suppli
antivir
drug
best
distribut
across
differ
risk
group
model
would
need
includ
differ
risk
group
take
account
stockpil
antivir
drug
vaccin
infinit
larg
altern
goal
investig
whether
local
contain
possibl
mean
target
antivir
drug
treatment
program
would
necessari
includ
spatial
structur
household
structur
possibl
also
workplac
structur
overal
howev
believ
present
state
knowledg
bare
suffic
make
realist
quantit
predict
effect
largescal
prophylact
antivir
drug
program
let
alon
possibl
make
quantit
predict
dynam
human
choic
taken
account
cours
tantamount
say
individu
choic
unimport
fortun
none
recent
viral
threat
anim
reservoir
avian
influenza
sar
succeed
get
definit
foothold
human
popul
consequ
key
epidemiolog
characterist
next
emerg
viru
transmiss
infecti
period
virul
remain
unknown
also
larg
true
rare
seriou
sideeffect
antivir
drug
render
attempt
provid
realist
predict
effect
control
measur
antivir
treatment
somewhat
specul
model
lack
much
sophist
earlier
model
suit
make
quantit
predict
rather
analys
laid
principl
guid
decis
ration
individu
public
health
offic
face
emerg
viral
threat
antivir
drug
deploy
first
line
defens
